Alabama has reached a $276 million settlement with two pharmaceutical manufacturers and a distributor to settle lawsuits over their roles in the opioid epidemic. The state's attorney general, Steve Marshall, announced the settlement agreement Tuesday, saying Alabama will receive $141 from pharmaceutical distributor McKesson Corporation, $70.3 million from Johnson & Johnson and $25 million from Endo Pharmaceutical. While the state will receive lump-sum payments from the two pharmaceutical manufactures, McKesson ...